Report cover image

Global Corticosteroid Eyedrops Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 116 Pages
SKU # APRC20548139

Description

Summary

According to APO Research, The global Corticosteroid Eyedrops market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Corticosteroid Eyedrops is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Corticosteroid Eyedrops is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Corticosteroid Eyedrops is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Corticosteroid Eyedrops include Alcon, Bausch & Lomb, Bausch & Lomb Inc, Cigna, Clear eyes, Meda Pharmaceuticals Inc, Rite Aid, Similasan Corporation and Staples, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Corticosteroid Eyedrops, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corticosteroid Eyedrops.
The Corticosteroid Eyedrops market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Corticosteroid Eyedrops market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Corticosteroid Eyedrops Segment by Company

Alcon
Bausch & Lomb
Bausch & Lomb Inc
Cigna
Clear eyes
Meda Pharmaceuticals Inc
Rite Aid
Similasan Corporation
Staples
Systane
Visine
Viva Opti-Free
Walgreens
Allergan, Inc.
Novartis AG
Corticosteroid Eyedrops Segment by Type

Tobradex
Cortisone
Dexamethasone
Others
Corticosteroid Eyedrops Segment by Application

Adult
Children
Corticosteroid Eyedrops Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Corticosteroid Eyedrops market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Corticosteroid Eyedrops and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Corticosteroid Eyedrops.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Corticosteroid Eyedrops manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Corticosteroid Eyedrops in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

116 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Corticosteroid Eyedrops Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Corticosteroid Eyedrops Sales Estimates and Forecasts (2020-2031)
1.3 Corticosteroid Eyedrops Market by Type
1.3.1 Tobradex
1.3.2 Cortisone
1.3.3 Dexamethasone
1.3.4 Others
1.4 Global Corticosteroid Eyedrops Market Size by Type
1.4.1 Global Corticosteroid Eyedrops Market Size Overview by Type (2020-2031)
1.4.2 Global Corticosteroid Eyedrops Historic Market Size Review by Type (2020-2025)
1.4.3 Global Corticosteroid Eyedrops Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Corticosteroid Eyedrops Sales Breakdown by Type (2020-2025)
1.5.2 Europe Corticosteroid Eyedrops Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Corticosteroid Eyedrops Sales Breakdown by Type (2020-2025)
1.5.4 South America Corticosteroid Eyedrops Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Corticosteroid Eyedrops Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Corticosteroid Eyedrops Industry Trends
2.2 Corticosteroid Eyedrops Industry Drivers
2.3 Corticosteroid Eyedrops Industry Opportunities and Challenges
2.4 Corticosteroid Eyedrops Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Corticosteroid Eyedrops Revenue (2020-2025)
3.2 Global Top Players by Corticosteroid Eyedrops Sales (2020-2025)
3.3 Global Top Players by Corticosteroid Eyedrops Price (2020-2025)
3.4 Global Corticosteroid Eyedrops Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Corticosteroid Eyedrops Major Company Production Sites & Headquarters
3.6 Global Corticosteroid Eyedrops Company, Product Type & Application
3.7 Global Corticosteroid Eyedrops Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Corticosteroid Eyedrops Market CR5 and HHI
3.8.2 Global Top 5 and 10 Corticosteroid Eyedrops Players Market Share by Revenue in 2024
3.8.3 2023 Corticosteroid Eyedrops Tier 1, Tier 2, and Tier 3
4 Corticosteroid Eyedrops Regional Status and Outlook
4.1 Global Corticosteroid Eyedrops Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Corticosteroid Eyedrops Historic Market Size by Region
4.2.1 Global Corticosteroid Eyedrops Sales in Volume by Region (2020-2025)
4.2.2 Global Corticosteroid Eyedrops Sales in Value by Region (2020-2025)
4.2.3 Global Corticosteroid Eyedrops Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Corticosteroid Eyedrops Forecasted Market Size by Region
4.3.1 Global Corticosteroid Eyedrops Sales in Volume by Region (2026-2031)
4.3.2 Global Corticosteroid Eyedrops Sales in Value by Region (2026-2031)
4.3.3 Global Corticosteroid Eyedrops Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Corticosteroid Eyedrops by Application
5.1 Corticosteroid Eyedrops Market by Application
5.1.1 Adult
5.1.2 Children
5.2 Global Corticosteroid Eyedrops Market Size by Application
5.2.1 Global Corticosteroid Eyedrops Market Size Overview by Application (2020-2031)
5.2.2 Global Corticosteroid Eyedrops Historic Market Size Review by Application (2020-2025)
5.2.3 Global Corticosteroid Eyedrops Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Corticosteroid Eyedrops Sales Breakdown by Application (2020-2025)
5.3.2 Europe Corticosteroid Eyedrops Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Corticosteroid Eyedrops Sales Breakdown by Application (2020-2025)
5.3.4 South America Corticosteroid Eyedrops Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Corticosteroid Eyedrops Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Alcon
6.1.1 Alcon Comapny Information
6.1.2 Alcon Business Overview
6.1.3 Alcon Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Alcon Corticosteroid Eyedrops Product Portfolio
6.1.5 Alcon Recent Developments
6.2 Bausch & Lomb
6.2.1 Bausch & Lomb Comapny Information
6.2.2 Bausch & Lomb Business Overview
6.2.3 Bausch & Lomb Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bausch & Lomb Corticosteroid Eyedrops Product Portfolio
6.2.5 Bausch & Lomb Recent Developments
6.3 Bausch & Lomb Inc
6.3.1 Bausch & Lomb Inc Comapny Information
6.3.2 Bausch & Lomb Inc Business Overview
6.3.3 Bausch & Lomb Inc Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bausch & Lomb Inc Corticosteroid Eyedrops Product Portfolio
6.3.5 Bausch & Lomb Inc Recent Developments
6.4 Cigna
6.4.1 Cigna Comapny Information
6.4.2 Cigna Business Overview
6.4.3 Cigna Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cigna Corticosteroid Eyedrops Product Portfolio
6.4.5 Cigna Recent Developments
6.5 Clear eyes
6.5.1 Clear eyes Comapny Information
6.5.2 Clear eyes Business Overview
6.5.3 Clear eyes Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Clear eyes Corticosteroid Eyedrops Product Portfolio
6.5.5 Clear eyes Recent Developments
6.6 Meda Pharmaceuticals Inc
6.6.1 Meda Pharmaceuticals Inc Comapny Information
6.6.2 Meda Pharmaceuticals Inc Business Overview
6.6.3 Meda Pharmaceuticals Inc Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Meda Pharmaceuticals Inc Corticosteroid Eyedrops Product Portfolio
6.6.5 Meda Pharmaceuticals Inc Recent Developments
6.7 Rite Aid
6.7.1 Rite Aid Comapny Information
6.7.2 Rite Aid Business Overview
6.7.3 Rite Aid Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Rite Aid Corticosteroid Eyedrops Product Portfolio
6.7.5 Rite Aid Recent Developments
6.8 Similasan Corporation
6.8.1 Similasan Corporation Comapny Information
6.8.2 Similasan Corporation Business Overview
6.8.3 Similasan Corporation Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Similasan Corporation Corticosteroid Eyedrops Product Portfolio
6.8.5 Similasan Corporation Recent Developments
6.9 Staples
6.9.1 Staples Comapny Information
6.9.2 Staples Business Overview
6.9.3 Staples Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Staples Corticosteroid Eyedrops Product Portfolio
6.9.5 Staples Recent Developments
6.10 Systane
6.10.1 Systane Comapny Information
6.10.2 Systane Business Overview
6.10.3 Systane Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Systane Corticosteroid Eyedrops Product Portfolio
6.10.5 Systane Recent Developments
6.11 Visine
6.11.1 Visine Comapny Information
6.11.2 Visine Business Overview
6.11.3 Visine Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Visine Corticosteroid Eyedrops Product Portfolio
6.11.5 Visine Recent Developments
6.12 Viva Opti-Free
6.12.1 Viva Opti-Free Comapny Information
6.12.2 Viva Opti-Free Business Overview
6.12.3 Viva Opti-Free Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Viva Opti-Free Corticosteroid Eyedrops Product Portfolio
6.12.5 Viva Opti-Free Recent Developments
6.13 Walgreens
6.13.1 Walgreens Comapny Information
6.13.2 Walgreens Business Overview
6.13.3 Walgreens Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Walgreens Corticosteroid Eyedrops Product Portfolio
6.13.5 Walgreens Recent Developments
6.14 Allergan, Inc.
6.14.1 Allergan, Inc. Comapny Information
6.14.2 Allergan, Inc. Business Overview
6.14.3 Allergan, Inc. Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Allergan, Inc. Corticosteroid Eyedrops Product Portfolio
6.14.5 Allergan, Inc. Recent Developments
6.15 Novartis AG
6.15.1 Novartis AG Comapny Information
6.15.2 Novartis AG Business Overview
6.15.3 Novartis AG Corticosteroid Eyedrops Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Novartis AG Corticosteroid Eyedrops Product Portfolio
6.15.5 Novartis AG Recent Developments
7 North America by Country
7.1 North America Corticosteroid Eyedrops Sales by Country
7.1.1 North America Corticosteroid Eyedrops Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Corticosteroid Eyedrops Sales by Country (2020-2025)
7.1.3 North America Corticosteroid Eyedrops Sales Forecast by Country (2026-2031)
7.2 North America Corticosteroid Eyedrops Market Size by Country
7.2.1 North America Corticosteroid Eyedrops Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Corticosteroid Eyedrops Market Size by Country (2020-2025)
7.2.3 North America Corticosteroid Eyedrops Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Corticosteroid Eyedrops Sales by Country
8.1.1 Europe Corticosteroid Eyedrops Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Corticosteroid Eyedrops Sales by Country (2020-2025)
8.1.3 Europe Corticosteroid Eyedrops Sales Forecast by Country (2026-2031)
8.2 Europe Corticosteroid Eyedrops Market Size by Country
8.2.1 Europe Corticosteroid Eyedrops Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Corticosteroid Eyedrops Market Size by Country (2020-2025)
8.2.3 Europe Corticosteroid Eyedrops Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Corticosteroid Eyedrops Sales by Country
9.1.1 Asia-Pacific Corticosteroid Eyedrops Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Corticosteroid Eyedrops Sales by Country (2020-2025)
9.1.3 Asia-Pacific Corticosteroid Eyedrops Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Corticosteroid Eyedrops Market Size by Country
9.2.1 Asia-Pacific Corticosteroid Eyedrops Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Corticosteroid Eyedrops Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Corticosteroid Eyedrops Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Corticosteroid Eyedrops Sales by Country
10.1.1 South America Corticosteroid Eyedrops Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Corticosteroid Eyedrops Sales by Country (2020-2025)
10.1.3 South America Corticosteroid Eyedrops Sales Forecast by Country (2026-2031)
10.2 South America Corticosteroid Eyedrops Market Size by Country
10.2.1 South America Corticosteroid Eyedrops Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Corticosteroid Eyedrops Market Size by Country (2020-2025)
10.2.3 South America Corticosteroid Eyedrops Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Corticosteroid Eyedrops Sales by Country
11.1.1 Middle East and Africa Corticosteroid Eyedrops Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Corticosteroid Eyedrops Sales by Country (2020-2025)
11.1.3 Middle East and Africa Corticosteroid Eyedrops Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Corticosteroid Eyedrops Market Size by Country
11.2.1 Middle East and Africa Corticosteroid Eyedrops Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Corticosteroid Eyedrops Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Corticosteroid Eyedrops Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Corticosteroid Eyedrops Value Chain Analysis
12.1.1 Corticosteroid Eyedrops Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Corticosteroid Eyedrops Production Mode & Process
12.2 Corticosteroid Eyedrops Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Corticosteroid Eyedrops Distributors
12.2.3 Corticosteroid Eyedrops Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.